ELENA-DANIELA GRIGORESCU, VICTORITA SORODOC, MARIANA FLORIA, ECATERINA ANISIE, ALINA DELIA POPA, ALINA ONOFRIESCU, ALEXANDR CEASOVSCHIH, LAURENTIU SORODOC THE INFLAMMATORY MARKER HSCRP AS A PREDICTOR OF INCREASED INSULIN RESISTANCE IN TYPE 2 DIABETICS WITHOUT ATHEROSCLEROTIC MANIFESTATIONS Low-grade inflammation is not only a specific feature in type 2 diabetes mellitus, but also a contributor to cardiovascular risk. Together with insulin resistance as the main characteristic of type 2 diabetes mellitus, subclinical imflammation maintains a vicious cycle of health-damaging processes. Our study assessed the inflammatory marker hsCRP in relation to the metabolic profiles of type 2 diabetic patients without clinical atherosclerotic manifestations. The results confirmed the hypothesized connection, which should be taken into consideration when designing and recommending diabetes care plans.
Keywords: hsCRP, insulin resistance, subclinical inflammation, type 2 diabetes mellitus